Pathogenesis of Antiphospholipid Syndrome.
作者信息
Bo Ic Borut
机构信息
Department of Rheumatology, University Medical Centre, Vodnikova 62, S1-1000 Ljubljana, Slovenia.
出版信息
EJIFCC. 2004 Aug 31;15(3):54-57. eCollection 2004 Aug.
Abstract
摘要
相似文献
1
Pathogenesis of Antiphospholipid Syndrome.抗磷脂综合征的发病机制。
EJIFCC. 2004 Aug 31;15(3):54-57. eCollection 2004 Aug.
2
[Antiphospholipid syndrome. Pathogenesis, molecular basis and clinical aspects].[抗磷脂综合征。发病机制、分子基础及临床方面]
Med Klin (Munich). 2001 Jun 15;96(6):331-42. doi: 10.1007/pl00002213.
3
Cofactor-Independent Antiphospholipid Antibodies: Implications for Pathogenesis, Diagnosis, and Treatment of Antiphospholipid Syndrome.无辅因子依赖性抗磷脂抗体：对抗磷脂综合征发病机制、诊断和治疗的影响。
Hamostaseologie. 2019 Jun;39(2):188-194. doi: 10.1055/s-0038-1675355. Epub 2018 Nov 12.
4
Common infectious agents prevalence in antiphospholipid syndrome.抗磷脂综合征中的常见感染因子流行情况。
Lupus. 2009 Nov;18(13):1149-53. doi: 10.1177/0961203309345738.
5
6
Prolactin's role in the pathogenesis of the antiphospholipid syndrome.催乳素在抗磷脂综合征发病机制中的作用。
Lupus. 2010 Nov;19(13):1515-9. doi: 10.1177/0961203310373781. Epub 2010 Jul 20.
7
Platelets and the antiphospholipid syndrome.血小板与抗磷脂综合征
Lupus. 2008 Oct;17(10):888-94. doi: 10.1177/0961203308096344.
8
The antiphospholipid syndrome and infections in a child with trisomy 21.一名21三体综合征患儿的抗磷脂综合征与感染
Autoimmun Rev. 2008 Dec;8(2):121-3. doi: 10.1016/j.autrev.2008.05.004. Epub 2008 Jun 23.
9
Antiphospholipid Syndrome with Antiβ2glicoprotein-1 Antibodies as the Cause of Recurrent Tibial Vein Thrombosis in SAPHO syndrome.以抗β2糖蛋白-1抗体为病因的抗磷脂综合征导致SAPHO综合征患者反复出现胫静脉血栓形成
Acta Dermatovenerol Croat. 2016 Dec;24(4):305-306.
10
The catastrophic antiphospholipid syndrome in children.儿童灾难性抗磷脂综合征
Curr Opin Rheumatol. 2017 Sep;29(5):516-522. doi: 10.1097/BOR.0000000000000426.
引用本文的文献
1
Antiphospholipid Syndrome: A Comprehensive Clinical Review.抗磷脂综合征：全面临床综述
J Clin Med. 2025 Jan 23;14(3):733. doi: 10.3390/jcm14030733.
本文引用的文献
1
Concomitant isolation of protein C inhibitor and unnicked beta2-glycoprotein I.同时分离出蛋白C抑制剂和未切割的β2-糖蛋白I。
Clin Chem Lab Med. 2004 Feb;42(2):171-4. doi: 10.1515/CCLM.2004.031.
2
THROMBOSIS IN SYSTEMIC LUPUS ERYTHEMATOSUS DESPITE CIRCULATING ANTICOAGULANTS.尽管存在循环抗凝物质，但系统性红斑狼疮患者仍发生血栓形成。
J Lab Clin Med. 1963 Sep;62:416-30.
3
High titers of autoantibodies to tissue factor pathway inhibitor are associated with the antiphospholipid syndrome.
J Thromb Haemost. 2003 Apr;1(4):718-24. doi: 10.1046/j.1538-7836.2003.00102.x.
4
Antiphospholipid syndrome: pathogenic mechanisms.抗磷脂综合征：致病机制
Autoimmun Rev. 2003 Mar;2(2):86-93. doi: 10.1016/s1568-9972(02)00144-1.
5
10th International Congress on Antiphospholipid Antibodies--summary.
Autoimmun Rev. 2003 Mar;2(2):79-85. doi: 10.1016/s1568-9972(02)00142-8.
6
Anti-annexin V antibodies in patients with cerebrovascular disease.脑血管疾病患者中的抗膜联蛋白V抗体。
Ann Rheum Dis. 2003 Feb;62(2):188-9. doi: 10.1136/ard.62.2.188.
7
Effects of beta2-glycoprotein I and monoclonal anticardiolipin antibodies in platelet interaction with subendothelium under flow conditions.β2-糖蛋白I和单克隆抗心磷脂抗体在流动条件下对血小板与内皮下层相互作用的影响。
Arthritis Rheum. 2002 Dec;46(12):3283-9. doi: 10.1002/art.10634.
8
beta 2 Glycoprotein I--a key player in the antiphospholipid syndrome.β2糖蛋白I——抗磷脂综合征中的关键因素。
Isr Med Assoc J. 2002 Nov;4(11 Suppl):958-62.
9
Molecular pathogenesis of the antiphospholipid syndrome.抗磷脂综合征的分子发病机制
Circ Res. 2002 Jan 11;90(1):29-37. doi: 10.1161/hh0102.102795.
10
Pathogenic mechanisms mediating antiphospholipid syndrome.介导抗磷脂综合征的致病机制。
Curr Opin Rheumatol. 2001 Sep;13(5):377-82. doi: 10.1097/00002281-200109000-00006.
Zotero 插件